Rectal cancer of moderately differentiated stage IIA can generally achieve some clinical cure, i.e., a chance of cure, after surgery and other treatments.
Rectal cancer is a common, malignant tumor caused by heredity, bad life habits and other factors. Stage IIA belongs to the middle early stage, which represents that the tumor has penetrated the intrinsic muscular layer to the subplasma layer; there is no lymph node metastasis; and there is no distant metastasis. Intermediate differentiation represents general differentiation of cancer cells and general prognosis.
With relatively early staging and limited lesions in this period, there are mostly chances of radical surgery to remove the lesions, and after surgery, supplemented with adjuvant treatments such as radiotherapy, chemotherapy, targeted therapy, etc. according to the condition, the patients can obtain a five-year survival rate of about 70%, and the prognosis is relatively good in general.
It is recommended that patients with moderately differentiated stage IIA rectal cancer should consult the doctor in time for standardized treatment under the doctor’s guidance, and have regular follow-up after surgery to prolong the survival period and improve the prognosis.